FTO and STAT3 Expression in Doxorubicin-Resistant Breast Cancer Cells

A research dataset from Wannan Medical College investigates the role of the FTO protein in STAT3-mediated doxorubicin resistance in breast cancer. The study includes data from experiments such as CHIP assays and dual luciferase reporter assays performed on doxorubicin-resistant and standard breast cancer cell lines. The dataset is associated with an open-access research paper.

Use Cases

• Modeling the relationship between FTO expression and doxorubicin resistance based on experimental knockdown/overexpression data
• Analyzing the correlation between STAT3 signaling activity and m6A modification levels described in the study
• Investigating transcriptional regulation mechanisms using promoter binding and activity data from CHIP and luciferase assays

Strengths

• Dataset is derived from controlled laboratory experiments including CHIP and dual luciferase reporter assays.
• Research focuses on a specific, clinically relevant mechanism of chemoresistance in breast cancer.

Limitations

• Row count and specific column definitions are unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Last update date is unknown; freshness unverified.

Provenance

Source

Wannan Medical College

Collection Method

Experimental data from molecular biology assays on breast cancer cell lines.